EUVIMEDEUVIMED entdecken
Crossref

Community-Acquired Respiratory Virus Infections: A Threat to Long-Term Survivors After Allogeneic Stem Cell Transplant?

José Luis Piñana iD, Juan A Carbonell-Asins, Dolores Gómez iD, Juan Montoro, Ariadna Pérez, Rafael Hernani, Pedro Chorão iD, Juan Carlos Hernández-Boluda, David Navarro, Carlos Solano

Clinical Infectious Diseases · 06.10.2025 · 81 (3) · 570-580

DOI: 10.1093/cid/ciae602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 05.12.2024. Verfasst von José Luis Piñana und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Hospital Clínico Universitario of Valencia, Spain. Hauptthemen laut MEDLINE: Community-Acquired Infections, Respiratory Tract Infections, Hematopoietic Stem Cell Transplantation, Survivors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Studies on late community-acquired respiratory virus (CARV) infections in long-term allogeneic hematopoietic stem cell transplantation (allo-HCT) survivors are scarce, creating knowledge gaps on the epidemiology, risk of progression to lower respiratory tract disease (LRTD), and conditions linked to poor outcomes.

Methods

We included consecutive CARV infection episodes occurring up to 6 months after allo-HCT registered in our database from December 2013 to June 2023 at 2 Spanish transplant centers.

Results

Among 426 allo-HCT recipients, 1070 CARV episodes were recorded, 791 (74%) with only upper respiratory tract disease (URTD) and 279 (15%) progressing to LRTD, at a median of 18.6 months post-transplant. The most common CARVs were rhinovirus, respiratory syncytial virus (RSV), and influenza. The LRTD progression rate was 26%, with a 4.9% all-cause mortality rate at 100 days post-CARV detection. Risk factors for LRTD progression included graft-versus-host disease prophylaxis (odds ratio [OR] 3.08), corticosteroid use (0.1 to <30 mg/day: OR 2.44; ≥30 mg/day: OR 5.19), absolute lymphocyte count (ALC) <1 × 10^9/L (OR 1.60), fever at CARV screening (OR 4.27), RSV (OR 2.46), and human metapneumovirus (HMPV) (OR 2.76). Risk factors for 100-day all-cause mortality included human leukocyte antigen (HLA) mismatch (hazard ratio [HR] 2.49); corticosteroid use (0.1 to <30 mg/day: HR 3.87; ≥30 mg/day: HR 5.77); ALC <1 × 10^9/L (HR 2.44); neutropenia <0.5 × 10^9/L (HR 6.74), and age ≥40 years (HR 4.85).

Conclusions

Recipients with profound and prolonged immunosuppression remain at risk for severe CARV infection outcomes late after allo-HCT, necessitating intensive clinical monitoring for respiratory symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Community-Acquired InfectionsRespiratory Tract InfectionsHematopoietic Stem Cell TransplantationSurvivorsVirus DiseasesHumansMaleFemaleMiddle AgedAdultRisk FactorsTransplantation, HomologousAgedYoung AdultAdolescentSpainGraft vs Host Disease

Stichwörter der Autor:innen

SARS-CoV-2allogeneic hematopoietic stem cell transplantationcommunity-acquired respiratory viruseshuman parainfluenza virushuman seasonal coronavirusinfluenzalate CARV infectionsmetapneumovirusrespiratory syncytial virusrhinovirus

Autor:innen und Institutionen

  • Department of Hematology, Hospital Clínico Universitario of Valencia, Spain.
  • INCLIVA, Biomedical Research Institute, Valencia, Spain.
  • Biostatistical department of INCLIVA, Biomedical Research Institute, Valencia, Spain.
  • Microbiology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Hematology Division, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.

ORCID-Profile: José Luis Piñana, Dolores Gómez, Pedro Chorão

Zitieren

APA

Piñana, J. L., Carbonell-Asins, J. A., Gómez, D., Montoro, J., Pérez, A., Hernani, R., Chorão, P., Hernández-Boluda, J. C., Navarro, D., & Solano, C. (2025). Community-Acquired Respiratory Virus Infections: A Threat to Long-Term Survivors After Allogeneic Stem Cell Transplant?. Clinical Infectious Diseases, 81(3), 570-580. https://doi.org/10.1093/cid/ciae602

Vancouver

Piñana JL, Carbonell-Asins JA, Gómez D, Montoro J, Pérez A, Hernani R, et al. Community-Acquired Respiratory Virus Infections: A Threat to Long-Term Survivors After Allogeneic Stem Cell Transplant?. Clinical Infectious Diseases. 2025;81(3):570-580. doi:10.1093/cid/ciae602

BibTeX
@article{Piana2025,
  author = {Piñana, José Luis and Carbonell-Asins, Juan A and Gómez, Dolores and Montoro, Juan and Pérez, Ariadna and Hernani, Rafael and Chorão, Pedro and Hernández-Boluda, Juan Carlos and Navarro, David and Solano, Carlos},
  title = {Community-Acquired Respiratory Virus Infections: A Threat to Long-Term Survivors After Allogeneic Stem Cell Transplant?},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  volume = {81},
  number = {3},
  pages = {570--580},
  doi = {10.1093/cid/ciae602}
}
Kostenlos starten →